Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification of Analytical Balances – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification of Analytical Balances – V 2.0

Standard Operating Procedure for Qualification of Analytical Balances in Method Development


Department Analytical Method Development
SOP No. SOP/AMD/389/2025
Supersedes SOP/AMD/389/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP is intended to establish a clear and consistent procedure for the qualification of analytical balances used within the Analytical Method Development (AMD) laboratory. Qualification of balances ensures their reliability, precision, and compliance with applicable regulatory

standards for use in accurate weighing of pharmaceutical materials.

2. Scope

This SOP applies to all new, relocated, or recalibrated analytical balances used in the AMD laboratory for development, validation, and transfer of analytical methods involving precise weighing activities.

3. Responsibilities

  • Analyst: Performs the qualification and records observations accurately in the qualification log.
  • Engineering/Maintenance: Assists in calibration and environmental setup during installation qualification.
  • QA Officer: Reviews qualification reports and ensures GMP compliance.
See also  Analytical Method Development: HPLC Assay Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all balances used in method development activities are qualified and maintained as per GMP and regulatory standards.

5. Procedure

5.1 Installation Qualification (IQ)

  1. Verify the manufacturer’s documentation including:
    • Instrument manual and specifications
    • Factory calibration certificate
    • Delivery note and warranty card
  2. Confirm placement on a vibration-free table, away from air currents and direct sunlight.
  3. Check availability of required electrical power supply with earthing.
  4. Record environmental conditions (temperature, humidity) at the installation location.

5.2 Operational Qualification (OQ)

  1. Switch on the balance and allow it to warm up for a minimum of 30 minutes.
  2. Perform internal or external calibration using certified weights (as per manufacturer’s instructions).
  3. Perform tests in triplicate for repeatability and accuracy using standard weights:
    • 1 g, 10 g, 20 g, 100 g and 200 g weights with class E2 or F1 tolerance
  4. Record displayed weights and calculate the deviation.
  5. Acceptable limit: ±0.1% of standard weight or as specified by internal policy.
See also  Analytical Method Development: Specificity Study Using HPLC - V 2.0

5.3 Performance Qualification (PQ)

  1. Conduct routine checks using internal check weights at the start of each weighing session.
  2. Simulate real-time use by weighing placebo materials or excipients typically used in method development.
  3. Ensure the balance provides reproducible and consistent results for analytical-grade materials.

5.4 Documentation and Review

  1. Record all test results in the Analytical Balance Qualification Form (Annexure-1).
  2. Review results against acceptance criteria and document any deviations.
  3. Compile final report and submit to QA for review and archival.

5.5 Requalification Triggers

  1. Relocation of the balance to a new environment.
  2. After major servicing or repair of any internal component.
  3. Annually, or as per equipment qualification matrix.

6. Abbreviations

  • IQ: Installation Qualification
  • OQ: Operational Qualification
  • PQ: Performance Qualification
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Analytical Balance Qualification Form – Annexure-1
  2. Calibration Certificate from Manufacturer – Annexure-2
See also  Analytical Method Development: Interpretation of NMR Spectra in AMD - V 2.0

8. References

  • USP General Chapter <41> Weights and Balances
  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211.68 – Automatic, Mechanical, and Electronic Equipment

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ravi Mehra Dr. Sujata Nair Dr. Harshita Goyal
Designation Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Analytical Balance Qualification Form

Weight (g) Displayed Weight (g) Deviation (%) Pass/Fail
1.000 1.001 +0.10 Pass
10.000 10.002 +0.02 Pass
100.000 99.996 -0.004 Pass

Annexure-2: Manufacturer Calibration Certificate

Includes original calibration certificate with serial number, calibration date, and traceability information to national/international standards.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Added performance qualification section and annexures Annual Review Dr. Harshita Goyal
10/06/2022 1.0 Initial release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Qualification of Chromatographic Columns – V 2.0
Next Post: Analytical Method Development: SOP for Handling Out of Trend (OOT) Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version